(Q42926932)

11 November 2017

title

Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study (English)

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.334

11 November 2017

Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study (English)

1 reference

22 June 2024

1 reference

1 reference

5

Peter D Siersema

1 reference

11 November 2017

Ofke S. van Boxel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736935

22 June 2024

Martijn G. H. van Oijen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736935

22 June 2024

Matthijs P. Hagenaars

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736935

22 June 2024

A. J P M. Smout

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736935

22 June 2024

language of work or name

English

0 references

publication date

24 August 2010

1 reference

full work available at URL

11 November 2017

https://journals.lww.com/ajg/Abstract/2010/11000/Cardiovascular_and_Gastrointestinal_Outcomes_in.20.aspx

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736935

http://www.nature.com/articles/ajg2010334.pdf

22 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.334

http://www.nature.com/articles/ajg2010334

22 June 2024

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.334

https://journals.lww.com/00000434-201011000-00020

22 June 2024

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.334

The American Journal of Gastroenterology

22 June 2024

published in

1 reference

11 November 2017

volume

105

1 reference

11 November 2017

issue

11

1 reference

11 November 2017

page(s)

2430-6; quiz 2437

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2010.334

11 November 2017

exact match

0 references

cites work

Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Risk factors for gastro-oesophageal reflux disease symptoms: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Channeling bias in the interpretation of drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.334

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

https://api.crossref.org/works/10.1038/AJG.2010.334

1

1 reference

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

22 June 2024

https://api.crossref.org/works/10.1038/AJG.2010.334

5

1 reference

ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use

22 June 2024

https://api.crossref.org/works/10.1038/AJG.2010.334

7

1 reference

Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.

22 June 2024

https://api.crossref.org/works/10.1038/AJG.2010.334

8

1 reference

Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel.

22 June 2024

https://api.crossref.org/works/10.1038/AJG.2010.334

16

1 reference

22 June 2024

Identifiers

DOI

10.1038/AJG.2010.334

1 reference

Dimensions Publication ID

11 November 2017

1046507731

0 references

1 reference